Humana Inc vs VanEck Semiconductor ETF — how do they compare? Humana Inc trades at $437.84 (market cap $47.61B), while VanEck Semiconductor ETF trades at $617.56 (market cap $76.96B). The key difference: VanEck Semiconductor ETF is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while VanEck Semiconductor ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and VanEck Semiconductor ETF for 101 Days on average.
| HUM | SMH | |
|---|---|---|
Market Cap | $47.61B | $76.96B |
Volume | 1,827,332 | 7,093,686 |
Sector | Health | — |
52-Week High | $409.85 | $668.91 |
52-Week Low | $163.67 | $325.10 |
Typical Hold Time | 53 Days | 101 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SMH (VanEck Semiconductor ETF) trades at $625.03, down 1.18% on the day but maintains strong bullish momentum with 69% year-to-date gains as of September 30, 2026. The ETF benefits from semiconductor sector strength, with technical indicators showing bullish moving averages but overbought RSI levels. Recent news highlights the fund's outperformance versus individual chip stocks and ongoing AI-driven demand.
Outlook remains positive given semiconductor market expansion projections, though concentration risk in top holdings and sector volatility present challenges. Bank of America forecasts the global chip market to nearly double by 2030, supporting long-term growth potential despite near-term technical overbought conditions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →